Back to results
US 2021/0332123 A1Published application
Anti-il-25 antibodies and use thereof
AssigneesSuzhou Kanova Biopharmaceutical Co., Ltd., Beijing Kanova Biopharmaceutical Co., Ltd.
InventorsLi Guo, Tiantian Sun, Xiaoxu Qi, Chen Dong
Life of this patent
Estimating the term…
Abstract
The present invention provides anti-IL-25 antibodies that are directed against (human) IL-25, nucleic acids that encode such antibodies, compositions, and in particular pharmaceutical compositions that comprise such antibodies; and uses of such antibodies and compositions.
Claims16
An anti-IL-25 antibody that (i) competes with murine antibody 18H3 for binding to (human) IL-25;
- and/or (ii) binds to the same epitope on (human) IL-25 as 18H3;
- and/or (iii) cross-blocks the binding of 18H3 to (human) IL-25.
16-17. (canceled)
Dependencies are inferred from the claim text.